BridgeBio Pharma (BBIO) PT Lowered to $55 at JPMorgan
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $76.57 --0%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on BridgeBio Pharma (NASDAQ: BBIO) to $55.00 (from $58.00) while maintaining a Overweight rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
- Azul SA (AZUL4:BZ) (AZUL) PT Lowered to R$31.50 at JPMorgan
- Konami Holdings Corp. (9766:JP) (KNMCY) PT Raised to JPY29,100 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
